As the shimmering stopped, I glanced around. We were on the deck of a large ship with no land in sight. As far as the eye could see there was water — Spirituality blue-green and beautiful. The gentle wind and
It included 1,445 schizophrenia patients randomly selected to receive one of five antipsychotic medications: olanzapine, perphenanize, quetiapine, risperidone or ziprasidone.
The panel of outside experts voted 14-to-2, at the end of a two-day meeting, to recommend that all makers of these drugs conduct long-term cardiovascular trials, even if the drugs show no signs of heart problems in initial trials.
But that hope is theoretical, because the formula hasn't been tested in humans. However, researchers from the University of Chicago report that they are one giant step closer to that reality, because they have designed a method that allows the
It's very hard to extrapolate from this finding to comment on the benefits of red wine directly, because red wine has many other compounds besides resveratrol, including ethanol, which have very active biological effects," noted study author Rafael de Cabo,
In the United States, a young competitive athlete dies every three days from an undetected cardiovascular disorder, according to background information in the study. In most of these kinds of cases, the athletes appear healthy and have no previous clinical
This is the same as any other part of the body. It's what we in vascular surgery refer to as the 'use it or lose it' concept," said Dr. Hossein Sadeghi-Nejad, an associate professor of urology at UMDNJ New Jersey
The first-of-its-kind study looked at almost half a million instances where nurses and other staff scanned patients and medications. In a remarkably high percentage of instances, nurses overrode the technology in order to compensate for awkward or inconvenient aspects of
Surgery is standard treatment for kidney cancer, but many patients are at risk of cancer recurrence because there is no effective adjuvant treatment, according to background information in the study by Dr. Christopher Wood, of the M.D. Anderson Cancer Center
Reuters Health - July 4, 2008NEW YORK - People who take part in clinical trials often do so out of a desire to advance scientific knowledge and to help others, a new international study demonstrates.'These results indicate that it is
Most available sunscreens are found to be not that effective and safe as advertised when it comes to protecting your skin from the sun.Environmental Working Group is a nonprofit organization, which decided to check the available sunscreen products for their
May 14, 2008 A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a woman's risk for developing breast cancer and provide a new approach for treatment, UT
IPSOGEN SA (Marseille and New Haven), a cancer profiler that develops and markets molecular diagnostic assays for blood & breast cancers, announced that researchers from the University of Texas MD Anderson Cancer Center (MDACC, Houston, TX) will present the results
Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical
Chicago -- The interaction of sex, age and ethnicity has a significant impact on overall survival in metastatic colorectal cancer (MCRC) patients, a study led by researchers at the University of Southern California (USC) and USC/Norris Comprehensive Cancer Center suggests.
Celator Pharmaceuticals reported positive results from its CPX-1 Phase 2 clinical trial in patients with advanced colorectal cancer. CPX-1 is a liposomal formulation of irinotecan and floxuridine, based on the company's proprietary CombiPlex(TM) technology. The results were presented in a
According to an article in the June issue of Radiology, researchers at The George Washington University Medical Center in Washington, D.C. have shown that Breast-Specific Gamma Imaging (BSGI) is highly sensitive in detecting the presence of cancer. The researchers determined
Poniard Pharmaceuticals, Inc. (NASDAQ:PARD), a biopharmaceutical company focused on oncology, announced positive preliminary results from its ongoing randomized Phase 2 clinical trial in patients with metastatic colorectal cancer (CRC) and updated results from an ongoing Phase 1 CRC trial. Preliminary
WILMINGTON, Mass. -- Sirtex, a leading developer of targeted and innovative cancer therapies, will exhibit its SIR-Spheres microspheres technology at the 2008 Society of Nuclear Medicine (SNM) Annual Meeting. The meeting, to be held June 14-18 at the Convention Center
